These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11887505)

  • 21. Cost-effectiveness of a smoking cessation program implemented at the time of surgery for lung cancer.
    Slatore CG; Au DH; Hollingworth W
    J Thorac Oncol; 2009 Apr; 4(4):499-504. PubMed ID: 19204575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
    Vijgen SM; van Baal PH; Hoogenveen RT; de Wit GA; Feenstra TL
    Health Educ Res; 2008 Apr; 23(2):310-8. PubMed ID: 17675649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing the burden of smoking world-wide: effectiveness of interventions and their coverage.
    Jha P; Chaloupka FJ; Corrao M; Jacob B
    Drug Alcohol Rev; 2006 Nov; 25(6):597-609. PubMed ID: 17132576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.
    Pichon-Riviere A; Augustovski F; Bardach A; Colantonio L;
    Value Health; 2011; 14(5 Suppl 1):S51-9. PubMed ID: 21839900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost-effectiveness of call-back counselling for smoking cessation.
    Lal A; Mihalopoulos C; Wallace A; Vos T
    Tob Control; 2014 Sep; 23(5):437-42. PubMed ID: 23748188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis.
    Verguet S; Gauvreau CL; Mishra S; MacLennan M; Murphy SM; Brouwer ED; Nugent RA; Zhao K; Jha P; Jamison DT
    Lancet Glob Health; 2015 Apr; 3(4):e206-16. PubMed ID: 25772692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avoiding the danger that stop smoking services may exacerbate health inequalities: building equity into performance assessment.
    Low A; Unsworth L; Low A; Miller I
    BMC Public Health; 2007 Aug; 7():198. PubMed ID: 17688681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?
    Menzin J; Lines LM; Marton J
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):257-64. PubMed ID: 19527098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The carbon footprint of behavioural support services for smoking cessation.
    Smith AJ; Tennison I; Roberts I; Cairns J; Free C
    Tob Control; 2013 Sep; 22(5):302-7. PubMed ID: 23481905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.
    Cromwell J; Bartosch WJ; Fiore MC; Hasselblad V; Baker T
    JAMA; 1997 Dec; 278(21):1759-66. PubMed ID: 9388153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why prevention can increase health-care spending.
    Temple NJ
    Eur J Public Health; 2012 Oct; 22(5):618-9. PubMed ID: 21914705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The total lifetime health cost savings of smoking cessation to society.
    Rasmussen SR; Prescott E; Sørensen TI; Søgaard J
    Eur J Public Health; 2005 Dec; 15(6):601-6. PubMed ID: 16014659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ending appreciable tobacco use in a nation: using a sinking lid on supply.
    Thomson G; Wilson N; Blakely T; Edwards R
    Tob Control; 2010 Oct; 19(5):431-5. PubMed ID: 20876079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The recent and projected public health and economic benefits of cigarette taxation in Greece.
    Alpert HR; Vardavas CI; Chaloupka FJ; Vozikis A; Athanasakis K; Kyriopoulos I; Bertic M; Behrakis PK; Connolly GN
    Tob Control; 2014 Sep; 23(5):452-4. PubMed ID: 23467654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of treating nicotine dependence: the Mayo Clinic experience.
    Croghan IT; Offord KP; Evans RW; Schmidt S; Gomez-Dahl LC; Schroeder DR; Patten CA; Hurt RD
    Mayo Clin Proc; 1997 Oct; 72(10):917-24. PubMed ID: 9379693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The economic impact of smoking in Germany.
    Ruff LK; Volmer T; Nowak D; Meyer A
    Eur Respir J; 2000 Sep; 16(3):385-90. PubMed ID: 11028648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
    Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M;
    S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The economic and human costs of smoking in Minnesota.
    Welch D; Daly K; Hilton J
    Minn Med; 1995 Apr; 78(4):19-22. PubMed ID: 7760782
    [No Abstract]   [Full Text] [Related]  

  • 40. The human and financial costs of smoking.
    Leistikow BN
    Clin Chest Med; 2000 Mar; 21(1):189-97, x-xi. PubMed ID: 10763099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.